CANTON – Life Sciences company MMS Holdings Inc. has appointed Kelly J. Hill to Executive Vice President of Global Business Operations and Strategy and Michelle Gayari to Executive Vice President of Global Operational Excellence and Innovation.

Hill and Gayari are long-time members of the executive leadership team at MMS, which has remained unchanged for the past decade. Both EVPs are Pfizer alumni and, along with Chief Scientific Officer and Founder Dr. Uma Sharma, who started the company after Pfizer closed its Ann Arbor operation in 2007.

“We are grateful for Kelly and Michelle’s contributions to MMS, and their sense of urgency and leadership has allowed us to considerably expand our teams and company globally,” said Prasad M. Koppolu, Chief Operating Officer, MMS.

Hill and Gayari have been instrumental in leading company advancements, including expanding services, acquiring new clients, and implementing the USD1M award for COVID-19 vaccine development that MMS announced last year. The company was awarded Best Data-Focused Biotech CRO in the International Life Sciences Awards.

In recent weeks, MMS surpassed a total of 800 colleagues across North America, Asia, Europe, and South Africa.

This year, MMS will conduct its second annual Global Champions of Change Competition in an effort to bring forth innovations from every level of the organization. The company currently has eight new innovations underway from the inaugural event, in addition to innovations in data science, medical writing, clinical trial transparency, and pharmacovigilance that are already in use by global sponsors.

Learn more at